Suchergebnisse - (Person:"Piantoni, Silvia")

PubPharm (7)

1

CXCL-13 serum levels in patients with rheumatoid arthritis treated with abatacept

enthalten in: Clinical and experimental rheumatology | 2022

von Masneri, S. | Piantoni, S. | Galoppini, G. | +5

2

Reply to : Anti-carbamylated protein antibodies are associated with early abatacept response in rheumatoid arthritis by Castellanos-Moreira et al

enthalten in: Clinical and experimental rheumatology | 2021

von Piantoni, S. | Bazzani, C. | Garrafa, E. | +3

CommentOn: Clin Exp Rheumatol. 2021 Sep-Oct;39(5):1142-1143. - PMID 33666163

3

Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept

enthalten in: Clinical and experimental rheumatology | 2021

von Kumar, R. | Piantoni, S. | Boldini, M. | +7

CommentIn: Clin Exp Rheumatol. 2021 Sep-Oct;39(5):1142-1143. - PMID 33666163

4

Circulating follicular helper T cells (CD4+CXCR5+ICOS+) decrease in patients with rheumatoid arthritis treated with abatacept

enthalten in: Clinical and experimental rheumatology | 2018

von Piantoni, S. | Regola, F. | Scarsi, M. | +2

5

Predictive factors of abatacept therapy discontinuation in patients with rheumatoid arthritis

enthalten in: Clinical rheumatology | 2016

von Piantoni, S. | Colombo, E. | Tincani, A. | +2

6

Serum levels of granzyme B decrease in patients with rheumatoid arthritis responding to abatacept

enthalten in: Clinical and experimental rheumatology | 2016

von Colombo, E. | Scarsi, M. | Piantoni, S. | +2

7

Abatacept reduces levels of switched memory B cells, autoantibodies, and immunoglobulins in patients with rheumatoid arthritis

enthalten in: The Journal of rheumatology | 2014

von Scarsi, M. | Paolini, L. | Ricotta, D. | +5

CommentIn: J Rheumatol. 2014 May;41(5):825-8. - PMID 24692519

1
[1]